From lightened crankshaft running on titanium conrods weighing about 40% less than iron components ... wheel articulation and on and off-road performance. Complete Customs assisted with the ...

In a report released yesterday, Tiago Fauth from Wells Fargo assigned a Buy rating to Disc Medicine (IRON – Research Report), with a price target of $91.00. The company’s shares closed ...

Disc Medicine (NASDAQ:IRON – Get Free Report)‘s stock had its “outperform” rating restated by equities researchers at Wedbush in a note issued to investors on Monday,RTT News reports.

In other Disc Medicine news, Director William Richard White sold 7,136 shares of the company’s stock in a transaction on Monday, November 4th. The shares were sold at an average price of $58.61 ...

In a report released today, Greg Harrison from Scotiabank maintained a Buy rating on Disc Medicine (IRON – Research Report), with a price target of $70.00. The company’s shares closed last ...

(RTTNews) - Disc Medicine Inc. (IRON), a clinical-stage biopharmaceutical company, Sunday, presented positive updated results from a Phase 1b trial evaluating its drug candidate DISC-0974 in ...

Results showed: DISC-3405 produced dose-related increases in serum hepcidin with corresponding reductions in serum iron across all dose levels; DISC-3405 resulted in deep reductions in serum iron ...

including AUD 1.1 billion upfront cash consideration for Onslow Iron Haul road recently received and a further AUD 804 million expected from sale of oil and gas assets to Hancock Prospecting.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...